HIGHLIGHTS
- who: Sugania Malar Chinapayan and collaborators from the Department of Surgery, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia NHMRC Chronic Kidney Disease Centre of Research Excellence, The University of Queensland have published the research work: Potential Value of Visfatin, Omentin-1, Nesfatin-1 and Apelin in Renal Cell Carcinoma (RCC): A Systematic Review and Meta-Analysis, in the Journal: Diagnostics 2022, 12, x FOR PEER REVIEW of 29/Nov/2022
- what: The authors explore the potential role and expression of visfatin, omentin-1, nesfatin-1 and apelin in the development and progression of RCC . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.